COR
Price
$365.45
Change
+$2.03 (+0.56%)
Updated
Nov 13 closing price
Capitalization
70.85B
82 days until earnings call
Intraday BUY SELL Signals
HSIC
Price
$73.34
Change
+$0.50 (+0.69%)
Updated
Nov 13 closing price
Capitalization
8.63B
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COR vs HSIC

Header iconCOR vs HSIC Comparison
Open Charts COR vs HSICBanner chart's image
Cencora
Price$365.45
Change+$2.03 (+0.56%)
Volume$1.31M
Capitalization70.85B
Henry Schein
Price$73.34
Change+$0.50 (+0.69%)
Volume$1.45M
Capitalization8.63B
COR vs HSIC Comparison Chart in %
COR
Daily Signal:
Gain/Loss:
HSIC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
COR vs. HSIC commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COR is a Buy and HSIC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (COR: $365.45 vs. HSIC: $73.34)
Brand notoriety: COR and HSIC are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: COR: 88% vs. HSIC: 91%
Market capitalization -- COR: $70.85B vs. HSIC: $8.63B
COR [@Medical Distributors] is valued at $70.85B. HSIC’s [@Medical Distributors] market capitalization is $8.63B. The market cap for tickers in the [@Medical Distributors] industry ranges from $104.45B to $0. The average market capitalization across the [@Medical Distributors] industry is $12.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COR’s FA Score shows that 4 FA rating(s) are green whileHSIC’s FA Score has 1 green FA rating(s).

  • COR’s FA Score: 4 green, 1 red.
  • HSIC’s FA Score: 1 green, 4 red.
According to our system of comparison, COR is a better buy in the long-term than HSIC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COR’s TA Score shows that 2 TA indicator(s) are bullish while HSIC’s TA Score has 6 bullish TA indicator(s).

  • COR’s TA Score: 2 bullish, 3 bearish.
  • HSIC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both COR and HSIC are a good buy in the short-term.

Price Growth

COR (@Medical Distributors) experienced а +1.45% price change this week, while HSIC (@Medical Distributors) price change was +4.68% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.80%. For the same industry, the average monthly price growth was -2.36%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

COR is expected to report earnings on Feb 04, 2026.

HSIC is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Medical Distributors (-0.80% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COR($70.9B) has a higher market cap than HSIC($8.63B). COR has higher P/E ratio than HSIC: COR (45.91) vs HSIC (23.14). COR YTD gains are higher at: 62.730 vs. HSIC (5.260). COR has higher annual earnings (EBITDA): 4.02B vs. HSIC (932M). COR has more cash in the bank: 2.23B vs. HSIC (145M). HSIC has less debt than COR: HSIC (3.36B) vs COR (8.24B). COR has higher revenues than HSIC: COR (317B) vs HSIC (12.8B).
CORHSICCOR / HSIC
Capitalization70.9B8.63B821%
EBITDA4.02B932M431%
Gain YTD62.7305.2601,193%
P/E Ratio45.9123.14198%
Revenue317B12.8B2,477%
Total Cash2.23B145M1,539%
Total Debt8.24B3.36B245%
FUNDAMENTALS RATINGS
COR vs HSIC: Fundamental Ratings
COR
HSIC
OUTLOOK RATING
1..100
2625
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
174
SMR RATING
1..100
1267
PRICE GROWTH RATING
1..100
828
P/E GROWTH RATING
1..100
1565
SEASONALITY SCORE
1..100
5037

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HSIC's Valuation (72) in the Medical Distributors industry is in the same range as COR (83) in the Real Estate Investment Trusts industry. This means that HSIC’s stock grew similarly to COR’s over the last 12 months.

COR's Profit vs Risk Rating (1) in the Real Estate Investment Trusts industry is significantly better than the same rating for HSIC (74) in the Medical Distributors industry. This means that COR’s stock grew significantly faster than HSIC’s over the last 12 months.

COR's SMR Rating (12) in the Real Estate Investment Trusts industry is somewhat better than the same rating for HSIC (67) in the Medical Distributors industry. This means that COR’s stock grew somewhat faster than HSIC’s over the last 12 months.

COR's Price Growth Rating (8) in the Real Estate Investment Trusts industry is in the same range as HSIC (28) in the Medical Distributors industry. This means that COR’s stock grew similarly to HSIC’s over the last 12 months.

COR's P/E Growth Rating (15) in the Real Estate Investment Trusts industry is somewhat better than the same rating for HSIC (65) in the Medical Distributors industry. This means that COR’s stock grew somewhat faster than HSIC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORHSIC
RSI
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
65%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
48%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
44%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
45%
Advances
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
50%
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
65%
Aroon
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
COR
Daily Signal:
Gain/Loss:
HSIC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGTSX24.320.12
+0.50%
Vanguard Total Intl Stock Index Inv
BHCFX20.760.09
+0.44%
Baron Health Care Retail
RGPAX24.220.05
+0.21%
RBC Global Opportunities A
AZNAX11.76N/A
N/A
Virtus Income & Growth A
CVMCX22.06-0.03
-0.14%
Calvert Emerging Markets Equity C

COR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COR has been closely correlated with MCK. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if COR jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COR
1D Price
Change %
COR100%
-0.45%
MCK - COR
73%
Closely correlated
-1.83%
CAH - COR
56%
Loosely correlated
-0.24%
SHTDF - COR
17%
Poorly correlated
N/A
OMI - COR
8%
Poorly correlated
+3.16%
HSIC - COR
8%
Poorly correlated
-0.52%
More

HSIC and

Correlation & Price change

A.I.dvisor tells us that HSIC and ZYXI have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
-0.52%
ZYXI - HSIC
32%
Poorly correlated
-5.17%
OMI - HSIC
16%
Poorly correlated
+3.16%
QIPT - HSIC
16%
Poorly correlated
-0.84%
SHTDY - HSIC
11%
Poorly correlated
+2.16%
MCK - HSIC
11%
Poorly correlated
-1.83%
More